Inventor · disambiguated record
Mohamad F. Jamiluddin
Also filed as: JAMILUDDIN MOHAMAD · JAMILUDDIN MOHAMAD F · JAMILUDDIN MOHAMAD FAKRUDDIN
8 granted patents·1 pending application·5 citations·filing 2007–2018
78Inventor score
Files withSENTINEXT THERAPEUTICS SDN BHD4AERAS GLOBAL TB VACCINE FOUND2AERAS GLOBAL TB VACCINE FOUNDATION1SADOFF JERALD C1THERAVECTYS1
Top patents by PatentIndex Score
9 records- 0179US7608256B2Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon responseAERAS GLOBAL TB VACCINE FOUND·Filed 2007·Granted Oct 27, 2009·3 cites·10 claims
- 0266US8658136B2Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon responseAERAS GLOBAL TB VACCINE FOUND·Filed 2013·Granted Feb 25, 2014·0 cites·16 claims
- 0365US9987350B2Antigens and vaccines directed against human enterovirusesSENTINEXT THERAPEUTICS SDN BHD·Filed 2012·Granted Jun 5, 2018·1 cites·4 claims
- 0465US7883696B2Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon responseAERAS GLOBAL TB VACCINE FOUNDATION·Filed 2009·Granted Feb 8, 2011·0 cites·9 claims
- 0564US8414884B2Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon responseSADOFF JERALD C·Filed 2010·Granted Apr 9, 2013·1 cites·7 claims
- 0654US10555997B2Antigens and vaccines directed against human enterovirusesSENTINEXT THERAPEUTICS SDN BHD·Filed 2018·Granted Feb 11, 2020·0 cites·3 claims
- 0754US10548964B2Antigens and vaccines directed against human enterovirusesSENTINEXT THERAPEUTICS SDN BHD·Filed 2018·Granted Feb 4, 2020·0 cites·9 claims
- 0843US2015056244A1Antigens and Vaccines Directed Against Human EnterovirusesSENTINEXT THERAPEUTICS SDN BHD·Filed 2014·Application pending·0 cites
- 0941US10864265B2Lentiviral vectors for expression of hepatitis B virus (HBV) antigensTHERAVECTYS·Filed 2017·Granted Dec 15, 2020·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →